Weekly Pre-IPO Stock Secondary Market Update | July 15, 2026

Blue Origin's $10 billion raise at a $130 billion valuation confirms that the space economy is no longer a single-company story, but the investable question is entry timing rather than whether Bezos and Blue Origin eventually execute. Reusable rockets are not yet in hand, and until they are, the revenue unlocks stay theoretical: constellations for communications, AI data centers in orbit, and the cadence SpaceX already runs at roughly three launches a day. The gap between here and there is funded by repeated capital raises, and an investor entering at $130 billion today could experience dilution approaching 80% before the business generates billions in revenue. That is survivable if the terminal outcome is a trillion-dollar company, which is precisely the SpaceX precedent that made a $200 billion mark look expensive at the time and cheap in hindsight. The longer-term prize is resource extraction rather than launch services, and the numbers there resist conventional underwriting: a Manhattan-sized iron ore asteroid within reach in perhaps 10 to 20 years carries a headline value near $10 quadrillion, helium-3 on the moon currently clears near $20 million per kilogram delivered, and Mars is an entire planet of unclaimed natural resources. China landing its own booster reinforces that the capability is diffusing rather than concentrating. Our view is that this is an exponential story priced by linear thinkers, which argues for owning the theme but sizing entry with discipline rather than conviction.

On OpenAI and Anthropic, we do not think either company needs the public markets to raise equity, and the persistent IPO chatter is likely mis-framed. Private capital is available to both in effectively unlimited size, and management commentary points to no urgency, with the OpenAI CFO signaling the company is not ready while Altman appears more open to it. The more credible catalyst is debt-market access. Bond issuers and banks penalize opacity, and they want quarterly financials plus a governance structure that has been tested under public scrutiny before they price at their best levels. The spread between public-company and private-company funding costs can run into the hundreds of basis points, which is material when the use of proceeds is data center construction and compute capacity converts almost directly into revenue capacity. Issuing equity to fund that buildout dilutes existing holders for no strategic reason, while cheaper debt makes the same math work and leaves the cap table intact. If either company goes public, we would read it as a funding-cost decision rather than a liquidity event, and the timing question becomes art rather than science, with a clean 20% first-day move being the outcome underwriters actually want.

Positron is the more actionable name this week, reportedly in talks to raise at roughly a $5 billion valuation as an inference-compute challenger to Nvidia. The architectural point common to this cohort, which includes Cerebras, SambaNova, Groq, and Etched, is memory on chip: keeping computation local rather than shuttling data between GPUs across a network cuts power consumption and raises speed, and the advantage compounds across sequential calculations. The macro tailwind is straightforward, because every incremental user and every incremental daily query is inference rather than training, so demand scales with adoption rather than with model development budgets. What separates Positron is that it is already post-revenue with a product customers are buying, which converts the bet from technology risk into execution and scale risk, a materially better place to underwrite in a sector where getting started is both expensive and hard. At a 20x revenue multiple, a billion dollars of revenue supports roughly a $20 billion mark, a 4x from $5 billion on a three to five year horizon, which sits in the zone we look for: real product-market fit, a growing end market, a competent management team, and a price that is neither speculative nor extended. The diligence that matters now is fab capacity and time allocation, since manufacturing at scale is what Groq solved domestically and what still separates the winners from the also-rans. We would hold more than one position across inference silicon, treat Etched as a smaller and earlier allocation given its pre-revenue status and lower valuation, and note that SambaNova at an $11 billion post-money carries a less attractive risk-adjusted setup along with aging investors who may push for a Cerebras-style listing to force liquidity.